BPG is committed to discovery and dissemination of knowledge
Cited by in CrossRef
For: Marks EI, Yee NS. Immunotherapeutic approaches in biliary tract carcinoma: Current status and emerging strategies. World J Gastrointest Oncol 2015; 7(11): 338-346 [PMID: 26600933 DOI: 10.4251/wjgo.v7.i11.338]
URL: https://www.wjgnet.com/1948-5204/full/v7/i11/338.htm
Number Citing Articles
1
Byoung Hyuck Kim, Kyubo Kim, Eui Kyu Chie, Jeanny Kwon, Jin-Young Jang, Sun Whe Kim, Do-Youn Oh, Yung-Jue Bang. Long-Term Outcome of Distal Cholangiocarcinoma after Pancreaticoduodenectomy Followed by Adjuvant Chemoradiotherapy: A 15-Year Experience in a Single InstitutionCancer Research and Treatment 2017; 49(2): 473 doi: 10.4143/crt.2016.166
2
Oraianthi Fiste, Ioannis Ntanasis-Stathopoulos, Maria Gavriatopoulou, Michalis Liontos, Konstantinos Koutsoukos, Meletios Athanasios Dimopoulos, Flora Zagouri. The Emerging Role of Immunotherapy in Intrahepatic CholangiocarcinomaVaccines 2021; 9(5): 422 doi: 10.3390/vaccines9050422
3
Xianzhe Yu, Lingling Zhu, Ting Wang, Jiang Chen. Immune microenvironment of cholangiocarcinoma: Biological concepts and treatment strategiesFrontiers in Immunology 2023; 14 doi: 10.3389/fimmu.2023.1037945
4
Anna Kasperska, Jędrzej Borowczak, Krzysztof Szczerbowski, Ewa Stec, Navid Ahmadi, Łukasz Szylber. Current Challenges in Targeting Tumor Desmoplasia to Improve the Efficacy of ImmunotherapyCurrent Cancer Drug Targets 2021; 21(11): 919 doi: 10.2174/1568009621666210825101456
5
Amir A. Rahnemai-Azar, Allison B. Weisbrod, Mary Dillhoff, Carl Schmidt, Timothy M. Pawlik. Intrahepatic cholangiocarcinoma: current management and emerging therapiesExpert Review of Gastroenterology & Hepatology 2017; 11(5): 439 doi: 10.1080/17474124.2017.1309290
6
Amit Mahipal, Anuhya Kommalapati, Sri Harsha Tella, Gaurav Goyal, Tushar C. Patel, Candice A. Bookwalter, Sean P. Cleary, Christopher L. Hallemeier, Rondell P. Graham. Evaluation and Management of Liver Masses2020; : 229 doi: 10.1007/978-3-030-46699-2_11
7
Alex B. Blair, Adrian Murphy. Immunotherapy as a treatment for biliary tract cancers: A review of approaches with an eye to the futureCurrent Problems in Cancer 2018; 42(1): 49 doi: 10.1016/j.currproblcancer.2017.10.004
8
Amit Mahipal, Anuhya Kommalapati, Sri Harsha Tella, Alexander Lim, Richard Kim. Novel targeted treatment options for advanced cholangiocarcinomaExpert Opinion on Investigational Drugs 2018; 27(9): 709 doi: 10.1080/13543784.2018.1512581
9
Ningyu Wang, Ai Huang, Bohua Kuang, Yu Xiao, Yong Xiao, Hong Ma. Progress in Radiotherapy for CholangiocarcinomaFrontiers in Oncology 2022; 12 doi: 10.3389/fonc.2022.868034
10
Bonala Sabeerabi, Venkat R. Arva Tatireddygari, Ramakrishna Vadde. Immunotherapy for Gastrointestinal MalignanciesDiagnostics and Therapeutic Advances in GI Malignancies 2020; : 113 doi: 10.1007/978-981-15-6487-1_8
11
Piamsiri Sawaisorn, Ahmed Gaballa, Kween Saimuang, Chaniya Leepiyasakulchai, Sakaorat Lertjuthaporn, Suradej Hongeng, Michael Uhlin, Kulachart Jangpatarapongsa. Human Vγ9Vδ2 T cell expansion and their cytotoxic responses against cholangiocarcinomaScientific Reports 2024; 14(1) doi: 10.1038/s41598-024-51794-1
12
Alphonse Charbel, Luca Tavernar, Thomas Albrecht, Fritz Brinkmann, Joanne Verheij, Eva Roos, Monika Nadja Vogel, Bruno Köhler, Christoph Springfeld, Alexander Brobeil, Peter Schirmacher, Stephan Singer, Arianeb Mehrabi, Stephanie Roessler, Benjamin Goeppert. Spatiotemporal analysis of tumour-infiltrating immune cells in biliary carcinogenesisBritish Journal of Cancer 2022; 127(9): 1603 doi: 10.1038/s41416-022-01933-0
13
Haihong Cheng, Di Zhou, Shouhua Wang, Jun Ding, Fei Ma. The immunological characteristics of gallbladder carcinoma and advances in immunotherapy practicesBioScience Trends 2021; 15(1): 9 doi: 10.5582/bst.2020.01039
14
Yanjun Sun, Junfeng Gong, Zhuang Li, Lin Han, Dengqun Sun. Gallbladder cancer: surgical treatment, immunotherapy, and targeted therapyPostgraduate Medicine 2024; 136(3): 278 doi: 10.1080/00325481.2024.2345585
15
Shuting Han, Suat Ying Lee, Who-Whong Wang, Yu Bin Tan, Rachel Hui Zhen Sim, Rachael Cheong, Cherlyn Tan, Richard Hopkins, John Connolly, Wai Ho Shuen, Han Chong Toh. A Perspective on Cell Therapy and Cancer Vaccine in Biliary Tract Cancers (BTCs)Cancers 2020; 12(11): 3404 doi: 10.3390/cancers12113404
16
Toshifumi Wakai, Masayuki Nagahashi, Yoshifumi Shimada, Pankaj Prasoon, Jun Sakata. Genetic analysis in the clinical management of biliary tract cancerAnnals of Gastroenterological Surgery 2020; 4(4): 316 doi: 10.1002/ags3.12334
17
Raed Al-Rajabi, Weijing Sun. Immunotherapy in cholangiocarcinomaCurrent Opinion in Gastroenterology 2021; 37(2): 105 doi: 10.1097/MOG.0000000000000715
18
Lionel A. Kankeu Fonkoua, Pedro Luiz Serrano Uson Junior, Kabir Mody, Amit Mahipal, Mitesh J. Borad, Lewis R. Roberts. Novel and emerging targets for cholangiocarcinoma progression: therapeutic implicationsExpert Opinion on Therapeutic Targets 2022; 26(1): 79 doi: 10.1080/14728222.2022.2029412
19
Nelson S. Yee, Eugene J. Lengerich, Kathryn H. Schmitz, Jennifer L. Maranki, Niraj J. Gusani, Leila Tchelebi, Heath B. Mackley, Karen L. Krok, Maria J. Baker, Claire de Boer, Julian D. Yee. Frontiers in Gastrointestinal Oncology: Advances in Multi-Disciplinary Patient CareBiomedicines 2018; 6(2): 64 doi: 10.3390/biomedicines6020064
20
Shiwei Yue, Yunpu Zhang, Wei Zhang. Recent Advances in Immunotherapy for Advanced Biliary Tract CancerCurrent Treatment Options in Oncology 2024; 25(8): 1089 doi: 10.1007/s11864-024-01243-y
21
Urvi A. Shah, Amara G. Nandikolla, Lakshmi Rajdev. Immunotherapeutic Approaches to Biliary CancerCurrent Treatment Options in Oncology 2017; 18(7) doi: 10.1007/s11864-017-0486-9
22
Joseph Ho, Constance Fiocco, Kristen Spencer. Treating Biliary Tract Cancers: New Targets and TherapiesDrugs 2022; 82(17): 1629 doi: 10.1007/s40265-022-01808-x
23
Changhoon Yoo, Do-Youn Oh, Hye Jin Choi, Masatoshi Kudo, Makoto Ueno, Shunsuke Kondo, Li-Tzong Chen, Motonobu Osada, Christoph Helwig, Isabelle Dussault, Masafumi Ikeda. Phase I study of bintrafusp alfa, a bifunctional fusion protein targeting TGF-β and PD-L1, in patients with pretreated biliary tract cancerJournal for ImmunoTherapy of Cancer 2020; 8(1): e000564 doi: 10.1136/jitc-2020-000564
24
Yuhao Zhao, Mao Yang, Jiayi Feng, Xu'an Wang, Yingbin Liu. Advances in immunotherapy for biliary tract cancersChinese Medical Journal 2024; 137(5): 524 doi: 10.1097/CM9.0000000000002759
25
Wen-Hui Luo, Shao-Jun Li, Xue-Feng Wang. Response of cholangiocarcinoma with epigastric metastasis to lenvatinib plus sintilimab: A case report and review of literatureWorld Journal of Gastrointestinal Oncology 2023; 15(11): 2033-2040 doi: 10.4251/wjgo.v15.i11.2033
26
GuanBo Zhang, JinSong Li, Gang Li, Jie Zhang, Zhi Yang, Lin Yang, ShiJie Jiang, JiaXing Wang. Strategies for treating the cold tumors of cholangiocarcinoma: core concepts and future directionsClinical and Experimental Medicine 2024; 24(1) doi: 10.1007/s10238-024-01460-7
27
Tiantian Wu, Changsheng Pu, Qiang Wang, Keming Zhang. Comparison of Efficacy and Safety of Anti-Programmed Cell Death-1 Antibody Plus Lenvatinib and Chemotherapy as First-Line Therapy for Patients with Stage IV Gallbladder Cancer: A Real-World Study in a Chinese PopulationBiomedicines 2023; 11(11): 2933 doi: 10.3390/biomedicines11112933
28
Sean Turbeville, Carl S. Hornfeldt, Milind Javle, Eric Tran, Marion Schwartz. Emerging therapies for the treatment of cholangiocarcinomaInternational Journal of Hepatobiliary and Pancreatic Diseases 2017; 7(2): 36 doi: 10.5348/ijhpd-2017-72-RA-8
29
Li-ming Zhao, An-da Shi, Yan Yang, Zeng-li Liu, Xiao-Qiang Hu, Li-Zhuang Shu, Yong-chang Tang, Zong-li Zhang. Advances in molecular and cell therapy for immunotherapy of cholangiocarcinomaFrontiers in Oncology 2023; 13 doi: 10.3389/fonc.2023.1140103
30
Juan W. Valle, Angela Lamarca, Lipika Goyal, Jorge Barriuso, Andrew X. Zhu. New Horizons for Precision Medicine in Biliary Tract CancersCancer Discovery 2017; 7(9): 943 doi: 10.1158/2159-8290.CD-17-0245
31
Luxi Yin, Qi Xu, Jingjing Li, Qing Wei, Jieer Ying. The efficiency and regimen choice of adjuvant chemotherapy in biliary tract cancerMedicine 2018; 97(50): e13570 doi: 10.1097/MD.0000000000013570
32
Aileen Deng, Steven Cohen. Primary and Metastatic Liver Tumors2018; : 137 doi: 10.1007/978-3-319-91977-5_11
33
A. M. Matilla Peña, A. Clemente Sánchez, E. Ramón Botella, D. Rincón. ColangiocarcinomaMedicine - Programa de Formación Médica Continuada Acreditado 2020; 13(12): 666 doi: 10.1016/j.med.2020.06.020
34
Cecilia Monge, Erica C Pehrsson, Changqing Xie, Austin G Duffy, Donna Mabry, Bradford J Wood, David E Kleiner, Seth M Steinberg, William D Figg, Bernadette Redd, Anuradha Budhu, Sophie Wang, Mayank Tandon, Lichun Ma, Xin Wei Wang, Tim F Greten. A Phase II Study of Pembrolizumab in Combination with Capecitabine and Oxaliplatin with Molecular Profiling in Patients with Advanced Biliary Tract CarcinomaThe Oncologist 2022; 27(3): e273 doi: 10.1093/oncolo/oyab073
35
Muzaffer Uğraklı, Mustafa Karaağaç, Mehmet Artaç. Handbook of Cancer and Immunology2023; : 1 doi: 10.1007/978-3-030-80962-1_218-1
36
Anwaar Saeed, Robin Park, Mohammed Al-Jumayli, Raed Al-Rajabi, Weijing Sun. Biologics, Immunotherapy, and Future Directions in the Treatment of Advanced CholangiocarcinomaClinical Colorectal Cancer 2019; 18(2): 81 doi: 10.1016/j.clcc.2019.02.005